Medlab Clinical Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medlab Clinical Ltd with three other
companies in this sector in AUSTRALIA :
sales of 5.82 million Australian Dollars [US$4.24 million]
of which 75%
was Advangen Japan),
Paradigm Biopharmaceuticals Ltd
(8.94 million Australian Dollars [US$6.52 million]
of which 100%
was Research and development of pharmaceutic), and
(4.19 million Australian Dollars [US$3.05 million]
Medlab Clinical Ltd reported sales of A$6.69 million (US$4.88 million)
June of 2021.
increase of 24.6%
versus 2020, when the company's sales were A$5.37 million.
Despite this increase, sales are still
below the level achieved in 2019, when Medlab Clinical Ltd
reported sales of A$7.80 million.
Sales of Corporate/ Other saw an increase
that was more than double the company's growth rate: sales were up
4,759.4% in 2021, from
A$76,142.00 to A$3.70 million.
Medlab Clinical Ltd also saw significant increases in sales in
Nutraceutical (up 70.4% to A$3.68 million)
Not all segments of Medlab Clinical Ltd experienced an increase in sales in 2021:
sales of Pharmaceutical Research fell 79.1% to A$747,747.00 .